118 related articles for article (PubMed ID: 2940963)
1. Effects of erythromycin and ciprofloxacin on chronic fecal excretion of Campylobacter species in marmosets.
Goodman LJ; Kaplan RL; Petrak RM; Fliegelman RM; Taff D; Walton F; Penner JL; Trenholme GM
Antimicrob Agents Chemother; 1986 Feb; 29(2):185-7. PubMed ID: 2940963
[TBL] [Abstract][Full Text] [Related]
2. Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni.
Pitkanen T; Pettersson T; Pomka A; Kosunen TU
J Infect Dis; 1982 Jan; 145(1):128. PubMed ID: 7054315
[No Abstract] [Full Text] [Related]
3. Emergence of resistance to erythromycin and fluoroquinolones in thermotolerant Campylobacter strains isolated from feces 1987-1991.
Reina J; Borrell N; Serra A
Eur J Clin Microbiol Infect Dis; 1992 Dec; 11(12):1163-6. PubMed ID: 1291314
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin.
Hirschl AM; Wolf D; Berger J; Rotter ML
Zentralbl Bakteriol; 1990 Apr; 272(4):443-7. PubMed ID: 2360966
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial Susceptibility of Campylobacter isolates in the Capital of North Macedonia.
Trajkovska-Dokic E; Mihajlov K; Mirchevska G; Kostovski M; Blazevska A; Stojkovska S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 Oct; 40(2):73-80. PubMed ID: 31605592
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic susceptibility profiles among Campylobacter isolates obtained from international travelers between 2007 and 2014.
Post A; Martiny D; van Waterschoot N; Hallin M; Maniewski U; Bottieau E; Van Esbroeck M; Vlieghe E; Ombelet S; Vandenberg O; Jacobs J
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2101-2107. PubMed ID: 28623550
[TBL] [Abstract][Full Text] [Related]
7. [Resistance monitoring working group: resistance to erythromycin, ciprofloxacin, and tetracycline in human isolates of Campylobacter spp. in the Czech Republic tested by the EUCAST standard method].
Žemličková H; Jakubů V; Marejková M; Urbášková P
Epidemiol Mikrobiol Imunol; 2014 Sep; 63(3):184-90. PubMed ID: 25412481
[TBL] [Abstract][Full Text] [Related]
8. A one-year study on thermophilic campylobacters isolated from fecal specimens.
Varoli O; Gatti M; Piscolla F
Microbiologica; 1989 Jul; 12(3):263-5. PubMed ID: 2674635
[TBL] [Abstract][Full Text] [Related]
9. Ciprofloxacin resistance among human Campylobacter isolates 1991-2004: an update.
Dingle KE; Clarke L; Bowler IC
J Antimicrob Chemother; 2005 Aug; 56(2):435-7. PubMed ID: 15956098
[No Abstract] [Full Text] [Related]
10. [Accuracy of Etest method to study Campylobacter spp. susceptibility to erythromycin, ciprofloxacin and tetracycline].
Sanz-Rodríguez N; Pérez-Pomata MT; Stelmakh O; Pérez-Boto D; Gómez-Garcés JL
Rev Esp Quimioter; 2013 Jun; 26(2):116-8. PubMed ID: 23817649
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial-resistant Campylobacter in the food chain in Mexico.
Zaidi MB; McDermott PF; Campos FD; Chim R; Leon M; Vazquez G; Figueroa G; Lopez E; Contreras J; Estrada-Garcia T
Foodborne Pathog Dis; 2012 Sep; 9(9):841-7. PubMed ID: 22870938
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal on-farm study of the development of antimicrobial resistance in Campylobacter coli from pigs before and after danofloxacin and tylosin treatments.
Juntunen P; Olkkola S; Hänninen ML
Vet Microbiol; 2011 Jun; 150(3-4):322-30. PubMed ID: 21397412
[TBL] [Abstract][Full Text] [Related]
13. Observations made on strains of Campylobacter spp. isolated in 1989 in northern Italy.
Varoli O; Gatti M; Montella MT; La Placa M
Microbiologica; 1991 Jan; 14(1):31-5. PubMed ID: 2067413
[TBL] [Abstract][Full Text] [Related]
14. Double-blind placebo controlled trial of erythromycin for treatment of Campylobacter enteritis.
Anders BJ; Lauer BA; Paisley JW; Reller LB
Lancet; 1982 Jan; 1(8264):131-2. PubMed ID: 6119512
[TBL] [Abstract][Full Text] [Related]
15. Erythromycin-resistant Campylobacter infections in Thailand.
Taylor DN; Blaser MJ; Echeverria P; Pitarangsi C; Bodhidatta L; Wang WL
Antimicrob Agents Chemother; 1987 Mar; 31(3):438-42. PubMed ID: 3579261
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tigecycline (GAR-936) and other antimicrobials against tetracycline- and ciprofloxacin-resistant Campylobacter clinical isolates.
Rodríguez-Avial I; Rodríguez-Avial C; López O; Culebras E; Picazo JJ
Int J Antimicrob Agents; 2006 Apr; 27(4):303-6. PubMed ID: 16540293
[TBL] [Abstract][Full Text] [Related]
17. [Erythromycin and ciprofloxacin resistant Campylobacter jejuni].
Afset JE; Maeland JA
Tidsskr Nor Laegeforen; 2001 Aug; 121(18):2152-4. PubMed ID: 11571989
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and antimicrobial resistance profile of Campylobacter spp. isolated from conventional and antimicrobial-free swine production systems from different U.S. regions.
Tadesse DA; Bahnson PB; Funk JA; Thakur S; Morrow WE; Wittum T; DeGraves F; Rajala-Schultz P; Gebreyes WA
Foodborne Pathog Dis; 2011 Mar; 8(3):367-74. PubMed ID: 21133777
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance among Campylobacter strains, United States, 1997-2001.
Gupta A; Nelson JM; Barrett TJ; Tauxe RV; Rossiter SP; Friedman CR; Joyce KW; Smith KE; Jones TF; Hawkins MA; Shiferaw B; Beebe JL; Vugia DJ; Rabatsky-Ehr T; Benson JA; Root TP; Angulo FJ;
Emerg Infect Dis; 2004 Jun; 10(6):1102-9. PubMed ID: 15207064
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of clinical isolates of non-jejuni/coli campylobacters and arcobacters from Belgium.
Vandenberg O; Houf K; Douat N; Vlaes L; Retore P; Butzler JP; Dediste A
J Antimicrob Chemother; 2006 May; 57(5):908-13. PubMed ID: 16533825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
